Distinct Roles for RAB10 and RAB29 in Pathogenic LRRK2-Mediated Endolysosomal Trafficking Alterations.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
17 07 2020
Historique:
received: 23 06 2020
revised: 12 07 2020
accepted: 13 07 2020
entrez: 26 7 2020
pubmed: 28 7 2020
medline: 5 3 2021
Statut: epublish

Résumé

Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) cause familial Parkinson's disease, and sequence variations are associated with the sporadic form of the disease. LRRK2 phosphorylates a subset of RAB proteins implicated in secretory and recycling trafficking pathways, including RAB8A and RAB10. Another RAB protein, RAB29, has been reported to recruit LRRK2 to the Golgi, where it stimulates its kinase activity. Our previous studies revealed that G2019S LRRK2 expression or knockdown of RAB8A deregulate epidermal growth factor receptor (EGFR) trafficking, with a concomitant accumulation of the receptor in a RAB4-positive recycling compartment. Here, we show that the G2019S LRRK2-mediated EGFR deficits are mimicked by knockdown of RAB10 and rescued by expression of active RAB10. By contrast, RAB29 knockdown is without effect, but expression of RAB29 also rescues the pathogenic LRRK2-mediated trafficking deficits independently of Golgi integrity. Our data suggest that G2019S LRRK2 deregulates endolysosomal trafficking by impairing the function of RAB8A and RAB10, while RAB29 positively modulates non-Golgi-related trafficking events impaired by pathogenic LRRK2.

Identifiants

pubmed: 32709066
pii: cells9071719
doi: 10.3390/cells9071719
pmc: PMC7407826
pii:
doi:

Substances chimiques

Rab29 protein, human 0
rab7 GTP-Binding Proteins 0
Epidermal Growth Factor 62229-50-9
LRRK2 protein, human EC 2.7.11.1
Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 EC 2.7.11.1
Rab10 protein, human EC 3.6.1.-
rab GTP-Binding Proteins EC 3.6.5.2
rab4 GTP-Binding Proteins EC 3.6.5.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Cold Spring Harb Perspect Biol. 2014 Oct 23;6(11):a022616
pubmed: 25341920
J Cell Sci. 2015 Apr 1;128(7):1386-99
pubmed: 25673874
J Biochem. 2015 Jun;157(6):485-95
pubmed: 25605758
J Cell Biol. 2019 Dec 2;218(12):4157-4170
pubmed: 31624137
J Cell Sci. 2019 Feb 19;132(5):
pubmed: 30700496
Sci Rep. 2016 Jul 18;6:29945
pubmed: 27424887
Sci Rep. 2017 Aug 31;7(1):10300
pubmed: 28860483
Biochem J. 2016 Sep 1;473(17):2671-85
pubmed: 27474410
Adv Neurobiol. 2017;14:241-264
pubmed: 28353288
J Biol Chem. 2009 May 1;284(18):12110-24
pubmed: 19265192
J Biol Chem. 2019 Jul 12;294(28):10954-10968
pubmed: 31152060
Front Neurosci. 2020 Jun 04;14:556
pubmed: 32581693
Biochem Soc Trans. 2019 Apr 30;47(2):651-661
pubmed: 30837320
Elife. 2020 May 11;9:
pubmed: 32391792
Biochem J. 2018 Jan 2;475(1):23-44
pubmed: 29127255
FEBS Lett. 2001 Apr 20;495(1-2):21-30
pubmed: 11322941
J Hum Genet. 2015 Jul;60(7):357-62
pubmed: 25855069
Am J Neurodegener Dis. 2013 Nov 29;2(4):287-99
pubmed: 24319646
Neuron. 2013 Feb 6;77(3):425-39
pubmed: 23395371
Hum Mol Genet. 2007 Sep 1;16(17):2031-9
pubmed: 17584768
Eur J Hum Genet. 2010 Dec;18(12):1356-9
pubmed: 20683486
Proc Natl Acad Sci U S A. 2012 Sep 25;109(39):15787-92
pubmed: 23019362
Neurosci Lett. 2017 Sep 14;657:179-188
pubmed: 28807727
Nat Neurosci. 2006 Oct;9(10):1231-3
pubmed: 16980962
J Biol Chem. 2018 Jan 12;293(2):731-739
pubmed: 29184002
Nat Genet. 2009 Dec;41(12):1308-12
pubmed: 19915575
Front Mol Neurosci. 2018 Nov 13;11:417
pubmed: 30483055
J Cell Physiol. 2018 Sep;233(9):6483-6494
pubmed: 29377137
Elife. 2017 Nov 10;6:
pubmed: 29125462
Mol Neurodegener. 2018 Jan 23;13(1):3
pubmed: 29357897
Curr Opin Cell Biol. 2019 Aug;59:34-39
pubmed: 30981180
Nat Med. 2010 Sep;16(9):998-1000
pubmed: 20729864
J Biol Chem. 2011 Oct 7;286(40):35196-208
pubmed: 21832070
Elife. 2016 Jan 29;5:
pubmed: 26824392
Hum Mol Genet. 2014 Dec 20;23(25):6779-96
pubmed: 25080504
Neurol Res. 2017 May;39(5):468-471
pubmed: 28245721
EMBO J. 2018 Jan 4;37(1):1-18
pubmed: 29212815
Hum Mol Genet. 2019 Nov 1;28(21):3552-3568
pubmed: 31428781
Cell Rep. 2020 May 5;31(5):107614
pubmed: 32375042
Neurobiol Dis. 2020 Jul;141:104948
pubmed: 32434048
Nat Rev Mol Cell Biol. 2002 Dec;3(12):893-905
pubmed: 12461556
Hum Mol Genet. 2012 Mar 15;21(6):1350-63
pubmed: 22171073
PLoS One. 2012;7(8):e43472
pubmed: 22952686
Neuron. 2016 Jan 6;89(1):37-53
pubmed: 26687838
Eur J Neurol. 2014 Oct;21(10):1337-43
pubmed: 25040112
Physiol Rev. 2011 Jan;91(1):119-49
pubmed: 21248164
J Cell Biol. 2013 Jul 22;202(2):191-9
pubmed: 23878272
Traffic. 2007 Jan;8(1):47-60
pubmed: 17132146
J Biol Chem. 2019 Mar 29;294(13):4738-4758
pubmed: 30709905
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2626-31
pubmed: 24510904
Nature. 2010 Jun 17;465(7300):942-6
pubmed: 20526321
Arch Neurol. 2012 Jan;69(1):105-10
pubmed: 22232350
Biochem J. 2018 Jan 2;475(1):1-22
pubmed: 29127256
PLoS Genet. 2012;8(2):e1002526
pubmed: 22363216
J Biol Chem. 2010 May 28;285(22):16814-21
pubmed: 20363736
Semin Cell Dev Biol. 2011 Feb;22(1):48-56
pubmed: 20951823
J Biol Chem. 2009 Jan 9;284(2):1213-23
pubmed: 19008234
PLoS One. 2017 Jun 5;12(6):e0179082
pubmed: 28582422
Hum Mol Genet. 2007 Jan 15;16(2):223-32
pubmed: 17200152
Mov Disord. 2019 Mar;34(3):406-415
pubmed: 30597610
J Cell Sci. 2014 Jan 15;127(Pt 2):422-31
pubmed: 24213529
Nat Rev Mol Cell Biol. 2009 Aug;10(8):513-25
pubmed: 19603039
J Biol Chem. 2006 Jan 13;281(2):1099-106
pubmed: 16282324
Science. 2018 Apr 6;360(6384):36-37
pubmed: 29622645
Mol Biol Cell. 2017 Mar 15;28(6):712-715
pubmed: 28292916
Biochem J. 2019 Oct 15;476(19):2797-2813
pubmed: 31527116
Cell Death Differ. 2015 Oct;22(10):1687-99
pubmed: 26021297
Neurol Res. 2015 Nov;37(11):1029-31
pubmed: 26344175
Curr Opin Cell Biol. 2013 Aug;25(4):414-9
pubmed: 23639309
Mol Biol Cell. 2016 Jul 1;27(13):2107-18
pubmed: 27170183
Neurobiol Dis. 2006 Aug;23(2):329-41
pubmed: 16750377
Hum Mol Genet. 2018 Jan 15;27(2):385-395
pubmed: 29177506
Mol Biol Cell. 2000 Feb;11(2):467-80
pubmed: 10679007
Mol Biol Cell. 2006 Jul;17(7):3156-75
pubmed: 16641372
Biochem J. 2007 Jul 15;405(2):307-17
pubmed: 17447891

Auteurs

Pilar Rivero-Ríos (P)

Institute of Parasitology and Biomedicine "López-Neyra", Consejo Superior de Investigaciones Científicas (CSIC), Avda del Conocimiento s/n, 18016 Granada, Spain.
Life Sciences Institute, University of Michigan, Ann Arbor, MI 48109, USA.

Maria Romo-Lozano (M)

Institute of Parasitology and Biomedicine "López-Neyra", Consejo Superior de Investigaciones Científicas (CSIC), Avda del Conocimiento s/n, 18016 Granada, Spain.

Belén Fernández (B)

Institute of Parasitology and Biomedicine "López-Neyra", Consejo Superior de Investigaciones Científicas (CSIC), Avda del Conocimiento s/n, 18016 Granada, Spain.

Elena Fdez (E)

Institute of Parasitology and Biomedicine "López-Neyra", Consejo Superior de Investigaciones Científicas (CSIC), Avda del Conocimiento s/n, 18016 Granada, Spain.

Sabine Hilfiker (S)

Department of Anesthesiology, New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, NJ 07103, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH